Alkem Laboratories Ltd
Mihir Doshi is an accomplished finance professional with extensive experience in the pharmaceutical and manufacturing sectors. Currently serving as General Manager at Alkem Laboratories Ltd. since April 2016, Mihir has held various significant positions within the company, including DGM, AGM, and Senior Manager roles focused on Manufacturing and R&D Finance, Third Party Costing, and Business Finance. Prior to this, Mihir worked at Cipla as FP&A Manager for the West Zone and at Glenmark Pharmaceuticals as Assistant Manager of International Finance. Mihir's career began at Waaree Group as Assistant Manager of Audit & Compliance. Mihir is a qualified Chartered Accountant, having completed education at the Indian Institute of Chartered Accountants, and holds a Bachelor's degree in Commerce from Nagindas Khandwala College.
This person is not in any teams
This person is not in any offices
Alkem Laboratories Ltd
9 followers
Alkem Laboratories Limited is a pharmaceutical company. The Company is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products. The Company operates through two segments: pharmaceutical and investing. The Company produces generics, generic drugs, active pharmaceutical ingredients (APIs) and neutraceuticals, which it markets in India and approximately 50 countries internationally, primarily the United States. The Company offers various products, such as CLAVAM 375, CLAVAM BID DRY SYRUP, CLAVAM INJ 300MG, FREEAIR NASAL SPRAY, PAN 40MG INJECTION (VIAL), PAN/40MG TABLETS, PROWEL DRY SYRUP (30ML), TAXCLAV 100 DT TABLETS, SATROGYL O DRY SYRUP, XONE/500MG VAIL, MEROSURE KIT 500, MEROSURE 500 MG and ZADONASE, among others. The Company has approximately 16 manufacturing facilities, of which 14 manufacturing facilities are at geographically diversified locations in India and two in the United States.